Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 19 studies | 49% ± 19% | |
peripheral blood | 19 studies | 47% ± 14% | |
intestine | 13 studies | 47% ± 25% | |
brain | 13 studies | 37% ± 12% | |
eye | 12 studies | 48% ± 24% | |
kidney | 9 studies | 48% ± 18% | |
bone marrow | 6 studies | 41% ± 17% | |
lymph node | 6 studies | 60% ± 16% | |
liver | 6 studies | 43% ± 15% | |
pancreas | 5 studies | 62% ± 24% | |
placenta | 4 studies | 62% ± 26% | |
uterus | 4 studies | 63% ± 17% | |
prostate | 4 studies | 52% ± 20% | |
breast | 4 studies | 56% ± 8% | |
adrenal gland | 3 studies | 46% ± 19% | |
skin | 3 studies | 37% ± 9% | |
thymus | 3 studies | 68% ± 33% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 5563.54 | 459 / 459 | 100% | 149.50 | 1118 / 1118 |
esophagus | 100% | 7002.92 | 1445 / 1445 | 100% | 81.25 | 183 / 183 |
lung | 100% | 5947.04 | 578 / 578 | 100% | 97.53 | 1155 / 1155 |
ovary | 100% | 7332.23 | 180 / 180 | 100% | 113.60 | 430 / 430 |
pancreas | 100% | 4133.57 | 328 / 328 | 100% | 82.01 | 178 / 178 |
stomach | 100% | 4411.38 | 359 / 359 | 100% | 83.98 | 286 / 286 |
uterus | 100% | 5840.23 | 170 / 170 | 100% | 144.02 | 459 / 459 |
thymus | 100% | 7740.70 | 653 / 653 | 100% | 126.37 | 604 / 605 |
intestine | 100% | 5652.65 | 966 / 966 | 100% | 92.07 | 526 / 527 |
brain | 100% | 3811.31 | 2639 / 2642 | 100% | 82.42 | 704 / 705 |
bladder | 100% | 5664.43 | 21 / 21 | 100% | 112.85 | 502 / 504 |
prostate | 100% | 7422.85 | 245 / 245 | 100% | 82.70 | 500 / 502 |
skin | 100% | 6244.53 | 1808 / 1809 | 98% | 78.41 | 462 / 472 |
kidney | 100% | 6088.00 | 89 / 89 | 97% | 60.40 | 876 / 901 |
adrenal gland | 100% | 4327.37 | 258 / 258 | 94% | 42.72 | 217 / 230 |
liver | 100% | 2385.22 | 226 / 226 | 92% | 45.59 | 375 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 182.14 | 29 / 29 |
spleen | 100% | 6621.69 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 113.58 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 70.39 | 1 / 1 |
adipose | 100% | 3811.46 | 1201 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 3525.81 | 1325 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 2616.10 | 838 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 48.83 | 75 / 80 |
peripheral blood | 87% | 5074.03 | 811 / 929 | 0% | 0 | 0 / 0 |
muscle | 60% | 827.50 | 482 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006325 | Biological process | chromatin organization |
GO_0032786 | Biological process | positive regulation of DNA-templated transcription, elongation |
GO_0048597 | Biological process | post-embryonic camera-type eye morphogenesis |
GO_0010225 | Biological process | response to UV-C |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000720 | Biological process | pyrimidine dimer repair by nucleotide-excision repair |
GO_0010224 | Biological process | response to UV-B |
GO_0050678 | Biological process | regulation of epithelial cell proliferation |
GO_0040034 | Biological process | regulation of development, heterochronic |
GO_0006283 | Biological process | transcription-coupled nucleotide-excision repair |
GO_0005654 | Cellular component | nucleoplasm |
GO_0001674 | Cellular component | female germ cell nucleus |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0031492 | Molecular function | nucleosomal DNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | HMGN1 |
Protein name | High mobility group nucleosome binding domain 1 (High-mobility group nucleosome binding domain 1, isoform CRA_d) Non-histone chromosomal protein HMG-14 (High mobility group nucleosome-binding domain-containing protein 1) High mobility group nucleosome binding domain 1 High-mobility group nucleosome binding domain 1 |
Synonyms | HMG14 hCG_401225 |
Description | FUNCTION: Binds to the inner side of the nucleosomal DNA thus altering the interaction between the DNA and the histone octamer. May be involved in the process which maintains transcribable genes in a unique chromatin conformation. Inhibits the phosphorylation of nucleosomal histones H3 and H2A by RPS6KA5/MSK1 and RPS6KA3/RSK2 (By similarity). . |
Accessions | ENST00000288344.14 ENST00000380749.10 P05114 ENST00000431390.5 F2Z2W6 ENST00000419378.5 Q6NSG7 H7BXJ5 Q3B790 A0A494C035 ENST00000652622.1 ENST00000443046.5 A6NEL0 ENST00000380747.5 ENST00000436324.5 F2Z2Y5 ENST00000380748.5 A6NL93 |